Approaches to improving cardiac structure and function during and after an acute myocardial infarction: Acute and chronic phases

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 21, Issue 4, 2016, Pages 363-367

  Kloner, Robert A ^a,b   Dai, Wangde ^a,b   Hale, Sharon L ^a   Shi, Jianru ^a,b  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acute myocardial infarction; Left ventricular remodeling; Myocardial infarct size; Reperfusion; Reperfusion injury

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE DISEASE; ACUTE HEART INFARCTION; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CARDIAC REGENERATON; CARDIAC STRUCTURE; CARDIOVASCULAR MORTALITY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HEALING; HEART; HEART FUNCTION; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TOTAL QUALITY MANAGEMENT; ANIMAL; CARDIAC MUSCLE; CELL DEATH; CONVALESCENCE; HEART LEFT VENTRICLE FUNCTION; MORTALITY; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; TIME FACTOR; TREATMENT OUTCOME;

ANIMALS; CELL DEATH; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; RECOVERY OF FUNCTION; REGENERATION; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84978818494     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248415616187     Document Type: Article

References (28)

1. Li YW,Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J. 1992;123(2):346-353.
2. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993:87(3):893-899.
3. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997;96(5):1641-1646.
4. Dai W, Herring MJ, Hale SL, Kloner RA. Rapid surface cooling by thermosuit system dramatically reduces scar size, prevents post-infarction adverse left ventricular remodeling, and improves cardiac function in rats. J Am Heart Assoc. 2015;4(7). pii: e002265.
5. Hale SL, Kloner RA. Mayocardial hypothermia: a potential therapeutic technique for acute regional myocardial ischemia. J Cardiovasc Electrophysiol. 1999:10(3):405-413.
6. Hammerman H, Kloner RA, Briggs L, Braunwald E. Enhancement of salvage of reperfused myocardium by early beta adrenergic blockade. J Am Coll Cardiol. 1984;3(6);1438-1443.
7. Hale SL, Herring MJ, Kloner RA. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc. 2013;2(1): e004234.
8. Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 2012;59(11):969-978.
9. Trabattoni D, Bartorelli AL, Fabbiocchi F, et al. Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2006;67(5):859-865.
10. Kitakaze M, Asakura M, Kim J, Shintani Y, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007;370(9597):1483-1493.
11. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Card. 2005; 45(11):1775-1780.
12. Crimi G, Pica S, Raineri C, et al. Remote ischemic postconditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial. JACC Cardiovasc Interv. 2013;6(10):1055-1063.
13. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomized trial. Lancet. 2010; 375(9716):727-734.
14. White SK, Frohlich GM, Sado DM, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Cardiovasc Interv. 2015;8(1 pt B):178-188.
15. Erlinge D, Götberg M, Lang I, et al. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. The CHILL-MI trial: a randomized controlled study of the use of central venous catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction. J Am Coll Cardiol. 2014;63(18):1857-1865.
16. Woo JS, Kim W, Ha SJ, et al. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol. 2013;33(9):2252-2260.
17. Latini R, Limbruno U, La Vecchia L, et al. on behalf of the CYCLE Investigators. Effect of cyclosporine A on infarct size reduction in reperfused acute myocardial infarction treated with primary angioplasty. Circulation. 2014;130(2S):A15211 (abstract).
18. Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015; 373(11):1021-1031.
19. Hammerman H, Kloner RA, Schoen FJ, Brown EJ, Jr, Hale SL, Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation. 1983;67(6):1290-1295.
20. Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation. 1983;68(2):446-452.
21. Gajarsa JJ, Kloner RA. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16(1): 13-21.
22. Dai W, Shi J, Gupta RC, Sabbah HN, Hale SL, Kloner RA. Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats. J Cardiovasc Pharmacol. 2014;64(6):543-553.
23. Müller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 2002;105(14):1720-1726.
24. Yao M, Dieterle T, Hale SL, Dow JS, Kedes LH, Peterson KL, Kloner RA. Long term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol. 2003;35(6):661-670.
25. Dai W, Field LJ, Rubart M, et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol. 2007;43(4):504-516.
26. Gallet R, Tseliou E, Dawkins J, et al. Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ Cardiovasc Interv. 2015;8. pii: e002391.
27. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med. 2007;2(1):63-68.
28. Dai W, Kay GL, Kloner RA. The therapeutic effect of cell transplantation versus noncellular biomaterial implantation on cardiac structure and function following myocardial infarction. J Cardiovasc Pharmacol Ther. 2014;19(4):350-357.